← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 30, 2019Last known activity
Aug 15, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (13)
- NCT05389813Study directorPhase 2/Phase 3Aug 15, 2021
- NCT05389813Lead sponsorPhase 2/Phase 3Aug 15, 2021
- NCT04923295Overall official - principal investigatorN/AJun 2, 2021
- NCT04923295Reponsible party - principal investigatorN/AJun 2, 2021
- NCT04923295Lead sponsorN/AJun 2, 2021
- NCT05271448Overall official - principal investigatorN/AJun 1, 2021
- NCT05271448Lead sponsorN/AJun 1, 2021
- NCT05271448Reponsible party - principal investigatorN/AJun 1, 2021
- NCT04981951Sponsor investigatorN/AOct 1, 2020
- NCT04981951Lead sponsorN/AOct 1, 2020
- NCT04981951Overall official - principal investigatorN/AOct 1, 2020
- NCT04981951Study directorN/AOct 1, 2020
- NCT03288571CollaboratorPhase 1/Phase 2Nov 30, 2019
Details
- Last known activity
- Aug 15, 2021